Suppository Drug Delivery Is Making a Comeback
In this episode of Bio Break, Nick and Nigel explore one of the oldest and most underappreciated drug delivery methods in modern medicine: the suppository. While often the subject of light humor, suppository drug delivery is gaining serious attention in the MedTech world for its effectiveness, ease of use, and broad applicability.
What Makes Suppositories Effective?
Suppositories are an example of non-oral drug delivery that bypasses the gastrointestinal system’s complex environment. Unlike oral tablets, which are subject to breakdown in the stomach and first-pass metabolism in the liver, suppositories can deliver medication directly into the bloodstream. This can lead to faster onset of action and greater bioavailability for certain drugs.
They’re particularly useful in scenarios where oral administration isn’t practical—such as when a patient is unconscious, vomiting, or otherwise unable to swallow medication. For these cases, suppository drug delivery provides a reliable and safe alternative.
Versatility in Drug Delivery
Suppositories are well-known for treating localized issues like hemorrhoids and constipation, but their role in systemic delivery is expanding. The slow-melting base at body temperature enables steady absorption, which can be ideal for sustained-release applications.
Nick and Nigel highlight the growing interest in advanced formulations like liposomes, nanoparticles, and mucoadhesives. These allow for more targeted delivery, longer duration of action, and better retention in mucosal tissues. Some formulations use thermosensitive materials that stay solid at room temperature but activate upon insertion—further enhancing delivery control.
A Resurgent Interest
According to Nick, the market for suppository-based drug delivery is growing, supported by promising research and real clinical needs. With an estimated 10% annual growth rate, this method is proving its value in both emerging therapies and everyday healthcare.
While suppositories may seem elementary, they continue to evolve—offering a reliable, low-cost solution in the right therapeutic context.
Learn more about StarFish Medical.
Related Resources
For manufacturers of novel devices that can make a significant impact to patient health, the goal of the program is to offer a path to streamlined and potentially faster market entry without sacrificing the rigour around ensuring safety and performance.
When I was starting out in medical devices, the discussion focused on the possibility of an internet of things and the promise of “big data” about everything.
With the release of ISO 14644-5:2025, Cleanrooms and associated controlled environments, Part 5: Operations, the standard places increased emphasis on operational discipline, human factors, and contamination control behaviour.
This article outlines the core elements of the PCCP framework, the types of modifications it applies to, and how the FDA expects manufacturers to use it in practice.